Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.39 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811190 | 0.81 | POLB (0.39) | GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL30367805 | 0.79 | GABBR2 (0.37) | GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL31462832 | 0.78 | POLB (0.36) | ALDH1A1GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL708899 | 0.78 | GABBR2 (0.36) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL14612293 | 0.78 | GABBR2 (0.39) | GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL21327677 | 0.78 | POLB (0.36) | ALDH1A1GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL2142578 | 0.78 | GABBR2 (0.36) | GABRA1GABRB2GABBR2GABBR1 | |
| SCHEMBL4157542 | 0.77 | GABBR2 (0.36) | GABRA1GABRB2GABBR2GABBR1CYP1A2 | |
| SCHEMBL709313 | 0.76 | DRD1 (0.36) | GABBR2GABBR1 | |
| SCHEMBL29415451 | 0.76 | RXRB (0.39) | ALDH1A1HPGDTDP1GABBR2GABBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116018334-A | Process for preparing 3- (cyclohex-1-en-1-yl) propanal derivatives | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-8110709-B2 | Stabilization of hydroformylation catalysts based on phosphoramide ligands | BASF SE (DE) | 2012-02-07 | — | — | US | disclosed |
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| EP-1677911-B1 | STABILIZATION OF HYDROFORMYLATION CATALYSTS BASED ON PHOSPHORAMIDE LIGANDS | BASF SE (DE) | 2010-06-16 | — | — | EP | disclosed |
| US-7615645-B2 | Method for the continuous production of aldehydes | BASF AKTIENGESELLSCHAFT (DE) | 2009-11-10 | — | — | US | disclosed |
| EP-1539666-B1 | METHOD FOR PRODUCING DIALDEHYDES AND/OR ETHYLENICALLY UNSATURATED MONOALDEHYDES BY HYDROFORMYLATING ETHYLENICALLY UNSATURATED COMPOUNDS | BASF SE (DE) | 2009-01-07 | — | — | EP | disclosed |
| CN-100412046-C | Method for the continuous production of aldehydes | BASF AG (DE) | 2008-08-20 | — | — | CN | disclosed |
| EP-1678113-B1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALDEHYDES | BASF SE (DE) | 2008-07-16 | — | — | EP | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1667950-A1 | METHOD FOR THE PRODUCTION OF 1.7-OCTADIENE AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-14 | — | — | EP | disclosed |
| US-20060052645-A1 | Method for producing dialdehydes and or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| WO-2005063730-A1 | METHOD FOR THE PRODUCTION OF XANTHENE-4,5-DIOLES SUBSTITUTED IN POSITION 2.7 | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | WO | disclosed |
| EP-1539666-A1 | METHOD FOR PRODUCING DIALDEHYDES AND/OR ETHYLENICALLY UNSATURATED MONOALDEHYDES BY HYDROFORMYLATING ETHYLENICALLY UNSATURATED COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-15 | — | — | EP | disclosed |
| WO-2005039762-A1 | STABILIZATION OF HYDROFORMYLATION CATALYSTS BASED ON PHOSPHORAMIDE LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-06 | — | — | WO | disclosed |
| WO-2005030681-A1 | METHOD FOR THE PRODUCTION OF 1.7-OCTADIENE AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | WO | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| EP-1470136-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-27 | — | — | EP | disclosed |
| WO-2004026803-A1 | METHOD FOR PRODUCING DIALDEHYDES AND/OR ETHYLENICALLY UNSATURATED MONOALDEHYDES BY HYDROFORMYLATING ETHYLENICALLY UNSATURATED COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-01 | — | — | WO | disclosed |
| WO-2003062251-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | CYP51A1, MSMO1, HSD17B7 | ALDH1A1 82/4885ALOX15 19/4885HPGD 37/4885 |
| US-20060052645-A1 | Method for producing dialdehydes and or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds | HPGD, PTGES, ALDH3A1 | ALDH1A1 87/4885ALOX15 169/4885HPGD 1/4885 |
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | ALDH1A1 4228/4885ALOX15 4075/4885HPGD 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.